Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 11/20 | 0.55 |
| ▸ | MMP1 | P03956 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP3 | P08254 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | MME | P08473 | 1/20 | 0.51 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.50 |
| ▸ | CTSD | P07339 | 1/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9848658 | 0.87 | BACE1 (0.53) | BACE1MMEBACE2CTSD | |
| SCHEMBL9848673 | 0.82 | BACE1 (0.53) | BACE1MMEBACE2CTSD | |
| SCHEMBL9848616 | 0.81 | BACE1 (0.57) | BACE1BACE2CTSD | |
| SCHEMBL29798307 | 0.81 | BACE1 (0.67) | BACE1BACE2CTSD | |
| SCHEMBL9848640 | 0.80 | BACE1 (0.55) | BACE1BACE2CTSD | |
| SCHEMBL9848655 | 0.80 | BACE1 (0.55) | BACE1BACE2CTSD | |
| SCHEMBL9848653 | 0.80 | BACE1 (0.54) | BACE1MMEBACE2CTSD | |
| SCHEMBL9848690 | 0.79 | OPRD1 (0.62) | BACE1BACE2CTSD | |
| SCHEMBL9848628 | 0.79 | BACE1 (0.59) | BACE1BACE2CTSD | |
| SCHEMBL9848664 | 0.79 | OPRD1 (0.61) | BACE1BACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0438873-A1 | Inhibitor of ribonucleotide reductase of herpes viruses | MERCK & CO. INC. (US) | 1991-07-31 | — | — | EP | disclosed |